Literature DB >> 31070638

Molecular mechanism of HIV-1 TAT peptide and its conjugated gold nanoparticles translocating across lipid membranes.

Xuebo Quan1, Delin Sun, Jian Zhou.   

Abstract

The trans-acting activator of transcription (TAT) peptide, which is derived from human immunodeficiency virus-1 (HIV-1), has been widely used as an effective nanocarrier to transport extracellular substances into cells. However, the underlying translocation mechanism of TAT peptide across cell membranes still remains controversial. Besides, the molecular process of TAT peptide facilitating the transport of extracellular substances into cells is largely unknown. In this study, we explore the interactions of TAT peptides and their conjugated gold nanoparticles with lipid membranes by coarse-grained molecular dynamics simulations. It is found that the TAT peptides can hardly penetrate through the membrane at low peptide concentrations; after the concentration increases to a threshold value, they can cross the membrane through an induced nanopore due to the transmembrane electrostatic potential difference. The translocation of TAT peptides is mainly caused by the overall structural changes of membranes. Furthermore, we demonstrate that the translocation of gold nanoparticles (AuNPs) across the membrane is significantly affected by the number of grafted TAT peptides on the particle surface. The transmembrane efficiency of AuNPs may even be reduced when a small number of peptides modify them; whereas, when the number of grafted peptides increases to a certain value, the TAT-AuNP complex can translocate across the membrane in a pore-mediated way. Based on our findings, an effective strategy has been proposed to enhance the delivery efficiency of AuNPs. The present study can improve our understanding of the interactions between TAT peptides and cell membranes; it may also give some insightful suggestions on the design and development of nanocarriers with high efficiency for the delivery of nanoparticles and drugs.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31070638     DOI: 10.1039/c9cp01543d

Source DB:  PubMed          Journal:  Phys Chem Chem Phys        ISSN: 1463-9076            Impact factor:   3.676


  4 in total

1.  TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19.

Authors:  Mohammad Azam Ansari; Qazi Mohammad Sajid Jamal; Suriya Rehman; Ahmad Almatroudi; Mohammad A Alzohairy; Mohammad N Alomary; Takshashila Tripathi; Ali H Alharbi; Syed Farooq Adil; Mujeeb Khan; M Shaheer Malik
Journal:  Arab J Chem       Date:  2020-10-01       Impact factor: 5.165

2.  Is It Possible to Find an Antimicrobial Peptide That Passes the Membrane Bilayer with Minimal Force Resistance? An Attempt at a Predictive Approach by Molecular Dynamics Simulation.

Authors:  Ilya V Likhachev; Nikolay K Balabaev; Oxana V Galzitskaya
Journal:  Int J Mol Sci       Date:  2022-05-26       Impact factor: 6.208

3.  Lipid-based nano delivery of Tat-peptide conjugated drug or vaccine-promising therapeutic strategy for SARS-CoV-2 treatment.

Authors:  Mohammad Azam Ansari; Ahmad Almatroudi; Mohammad A Alzohairy; Sami AlYahya; Mohammad N Alomary; Hanan A Al-Dossary; Saad Alghamdi
Journal:  Expert Opin Drug Deliv       Date:  2020-08-31       Impact factor: 6.648

Review 4.  Nanotechnology: A Potential Weapon to Fight against COVID-19.

Authors:  Atul K Tiwari; Anupa Mishra; Govind Pandey; Munesh K Gupta; Prem C Pandey
Journal:  Part Part Syst Charact       Date:  2021-11-21       Impact factor: 3.467

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.